Grail Inc., a developer of cancer tests, disclosed on Friday that a telemedicine vendor, PWNHealth, mistakenly sent 400 patients letters indicating they could have gotten cancer. This is according to a Reuters report released on Monday, June 05, 2023.
More than 50 different forms of cancer may be identified with Grail’s flagship cancer detection blood test Galleri before symptoms arise.
The letters were issued accidentally by PWNHealth owing to a software glitch, according to the business, which is owned by Illumina Inc. It was claimed that the error “was in no way related to or caused by an incorrect Galleri test result.”
Grail stated that it quickly contacted the patients and that no patient health information was leaked or compromised as a result of the incident.
PWNHealth’s software problem has been rectified, according to the company.
Illumina is now challenging regulatory rulings in the United States and the European Union that require the gene sequencing giant to unload Grail after skipping authorities to complete its acquisition of the cancer test producer.